Exposure of quantum dots in the nervous system: Central nervous system risks and the blood–brain barrier interface.

Quantum dots currently possess significant importance in the field of biomedical science. Upon introduction into the body, quantum dots exhibit a tendency to accumulate in diverse tissues including the central nervous system (CNS). Consequently, it becomes imperative to devote specific attention to their potential toxic effects. Moreover, the preservation of optimal CNS function relies heavily on blood–brain barrier (BBB) integrity, thereby necessitating its prioritization in neurotoxicological investigations. A more comprehensive understanding of the BBB and CNS characteristics, along with the underlying mechanisms that may contribute to neurotoxicity, will greatly aid researchers in the development of effective design strategies. This article offers an in‐depth look at the methods used to reduce the harmful effects of quantum dots on the nervous system, alongside the progression of effective treatments for brain‐related conditions. The focal point of this discussion is the BBB and its intricate association with the CNS and neurotoxicology. The discourse commences by recent advancements in the medical application of quantum dots are examined. Subsequently, elucidating the mechanisms through which quantum dots infiltrate the human body and traverse into the brain. Additionally, the discourse delves into the factors that facilitate the passage of quantum dots across the BBB, primarily encompassing the physicochemical properties of quantum dots and the BBB's inherent capacity for self‐permeability alteration. Furthermore, a concluding summary is presented, emphasizing existing research deficiencies and identifying promising avenues for further investigation within this field. This article explores quantum dots' biomedical applications, emphasizing their potential neurotoxicity and impact on the blood‐brain barrier (BBB). It discusses methods to mitigate quantum dots' harmful effects on the nervous system and highlights advancements in brain‐related treatments. The focus is on understanding BBB integrity, quantum dots' mechanisms of entry into the CNS, and factors influencing their passage across the barrier. The conclusion underscores research gaps and suggests future avenues for investigation in this field. [ABSTRACT FROM AUTHOR]